SCHEMBL4980423

SCHEMBL4980423

Cc1cc(Cl)ccc1OCC(=O)N1CCc2cnc(N3CCN(C4CCC4)CC3)nc2CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.56
KDM4E B2RXH2 1/20 0.56
SMN1; SMN2 Q16637 4/20 0.52
TSHR P16473 2/20 0.52
GAA P10253 2/20 0.52
NPC1 O15118 2/20 0.52
HPGD P15428 2/20 0.52
HTT P42858 2/20 0.52
MAPK1 P28482 1/20 0.52
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
ALDH1A1 P00352 1/20 0.49
TP53 P04637 2/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.46
RAB9A P51151 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HSP90AB1 P08238 1/20 0.42
MCHR1 Q99705 1/20 0.41
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4980666 0.92 SMN1; SMN2 (0.51) LMNAKDM4ESMN1; SMN2TSHRGAA
SCHEMBL4978277 0.92 HTT (0.52) LMNAKDM4ESMN1; SMN2TSHRGAA
SCHEMBL4978729 0.91 LMNA (0.45) LMNAKDM4ESMN1; SMN2TSHRGAA
SCHEMBL4979744 0.88 MEN1 (0.50) LMNAKDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL4976178 0.87 MEN1 (0.50) LMNAKDM4ESMN1; SMN2GAANPC1
SCHEMBL4980209 0.87 POLB (0.52) KDM4ESMN1; SMN2HPGDALDH1A1POLB
SCHEMBL4975188 0.85 FKBP1A (0.47) KDM4ESMN1; SMN2POLBMAPTNPSR1
SCHEMBL4975411 0.85 MEN1 (0.47) LMNAKDM4ESMN1; SMN2HTTMEN1
SCHEMBL4979902 0.85 KDM4E (0.54) KDM4ESMN1; SMN2TSHRNPC1HTT
SCHEMBL14346546 0.84 HSP90AB1 (0.40) LMNAKDM4ESMN1; SMN2TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES HRH3, HRH4, HRH2 LMNA 4534/4885KDM4E 1865/4885SMN1; SMN2 3880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.